BMJ Best Practice

参考文献

关键文献

American Academy of Ophthalmology Cornea/External Disease Panel. Preferred practice pattern: blepharitis. October 2013. http://one.aao.org (last accessed 20 February 2017).

McCulley JP, Dougherty JM, Deneau DG. Classification of chronic blepharitis. Ophthalmology. 1982;89:1173-1180.

NHS Choices. Blepharitis. May 2010. http://www.nhs.uk/ (last accessed 20 February 2017).

Mathers WD, Shields WJ, Sachdev MS, et al. Meibomian gland dysfunction in chronic blepharitis. Cornea. 1991;10:277-285.

Lindsley K, Matsumura S, Hatef E, Akpek EK. Interventions for chronic blepharitis. Cochrane Database Syst Rev. 2012;5:CD005556.

参考文章

1.  American Academy of Ophthalmology Cornea/External Disease Panel. Preferred practice pattern: blepharitis. October 2013. http://one.aao.org (last accessed 20 February 2017).

2.  Smith RE, Flowers CW Jr. Chronic blepharitis: a review. CLAO J. 1995;21:200-207.

3.  McCulley JP, Dougherty JM, Deneau DG. Classification of chronic blepharitis. Ophthalmology. 1982;89:1173-1180.

4.  McCulley JP, Sciallis GF. Meibomian keratoconjunctivitis. Am J Ophthalmol. 1977;84:788-793.

5.  Stone DU, Chodosh J. Ocular rosacea: an update on pathogenesis and therapy. Curr Opin Ophthalmol. 2004;15:499-502.

6.  Driver PJ, Lemp MA. Meibomian gland dysfunction. Surv Ophthalmol. 1996;40:343-367.

7.  NHS Choices. Blepharitis. May 2010. http://www.nhs.uk/ (last accessed 20 February 2017).

8.  IMS America. National disease and therapeutic index. Ambler, PA: IMS America, Ltd., 1984.

9.  Dougherty JM, McCulley JP. Comparative bacteriology of chronic blepharitis. Br J Ophthalmol. 1984;68:524-528.

10.  Groden LR, Murphy B, Rodnite J, et al. Lid flora in blepharitis. Cornea. 1991;10:50-53.

11.  Thygeson P. Etiology and treatment of blepharitis. Arch Ophthalmol. 1946;36:445-477.

12.  Dougherty JM, McCulley JP. Bacterial lipases and chronic blepharitis. Invest Ophthalmol Vis Sci. 1986;27:486-491.

13.  McCulley JP, Dougherty M. Bacterial aspects of chronic blepharitis. Trans Ophthalmol Soc U.K. 1986;105:314-318.

14.  Shine WE, Silvany R, McCulley JP. Relation of cholesterol-stimulated Staphylococcus aureus growth to chronic blepharitis. Invest Ophthalmol Vis Sci. 1993;34:2291-2296.

15.  Allen JH. Staphylococcic conjunctivitis. Am J Ophthalmol. 1937;20:1025-1031.

16.  Thygeson P. Bacterial factors in chronic catarrhal conjunctivitis. Arch Ophthalmol. 1937;18:373-387.

17.  Seal D, Ficker L, Ramakrishnan M, et al. Role of staphylococcal toxin production in blepharitis. Ophthalmology. 1990;92:1684-1688.

18.  Mondino BJ, Caster AI, Dethlefs B. A rabbit model of staphylococcal blepharitis. Arch Ophthalmol. 1987;105:409-412.

19.  Ficker L, Ramakrishnan M, Seal D, et al. Role of cell-mediated immunity to staphylococci in blepharitis. Am J Ophthalmol. 1991;111:473-479.

20.  Mathers WD, Shields WJ, Sachdev MS, et al. Meibomian gland dysfunction in chronic blepharitis. Cornea. 1991;10:277-285.

21.  Jester JV, Nicolaides N, Smith RE. Meibomian gland dysfunction. Invest Ophthalmol Vis Sci. 1989;30:927-935.

22.  Dougherty JM, McCulley JP. Analysis of the free fatty acid component of meibomian secretions in chronic blepharitis. Invest Ophthalmol Vis Sci. 1986;27:52-56.

23.  Shine WE, McCulley JP. The role of cholesterol in chronic blepharitis. Invest Ophthalmol Vis Sci. 1991;32:2272-2280.

24.  Shine WE, McCulley JP. Meibomianitis: polar lipid abnormalities. Cornea. 2004;23:781-783.

25.  Akpek EK, Polcharoen W, Chan R, et al. Ocular surface neoplasia masquerading as chronic blepharoconjunctivitis. Cornea. 1999;18:282-288.

26.  Brownstein B, Codere F, Jackson WB. Masquerade syndrome. Ophthalmology. 1980;87:259.

27.  Gao YY, Di Pascuale M, Li W, et al. High prevalence of Demodex in eyelashes with cylindrical dandruff. Invest Ophthalmol Vis Sci. 2005;46:3089-3094.

28.  Key JE. A comparative study of eyelid cleaning regimens in chronic blepharitis. CLAO J. 1996;22:209-212.

29.  Bowman RW, Dougherty JM, McCulley JP. Chronic blepharitis and dry eyes. Int Ophthalmol Clin. 1987;27:27-35.

30.  Perry HD, Doshi-Carnevale S, Donnenfeld ED, et al. Efficacy of commercially available topical cyclosporine A 0.05% in the treatment of meibomian gland dysfunction. Cornea. 2006;25:171-175.

31.  Lindsley K, Matsumura S, Hatef E, Akpek EK. Interventions for chronic blepharitis. Cochrane Database Syst Rev. 2012;5:CD005556.

32.  O'Gallagher M, Bunce C, Hingorani M et al. Topical treatment for blepharokeratoconjunctivitis (BKC) in children. Cochrane Database Syst Rev 2017;2:CD011965.

33.  Smolin G, Okumoto M. Staphylococcal blepharitis. Arch Ophthalmol. 1977;95:812-816.

34.  Opitz DL, Tyler KF. Efficacy of azithromycin 1% ophthalmic solution for treatment of ocular surface disease from posterior blepharitis. Clin Exp Optom. 2011;94:200-206.

35.  Luchs J. Efficacy of topical azithromycin ophthalmic solution 1% in the treatment of posterior blepharitis. Adv Ther. 2008;25:858-870.

36.  Haque RM, Torkildsen GL, Brubaker K, et al. Multicenter open-label study evaluating the efficacy of azithromycin ophthalmic solution 1% on the signs and symptoms of subjects with blepharitis. Cornea. 2010;29:871-877.

37.  Lamberts DW, Buka T, Knowlton GM. Clinical evaluation of trimethoprim-containing ophthalmic solutions in humans. Am J Ophthalmol. 1984;98:11-16.

38.  Miller IM, Vogel R, Cook TJ, et al. Topically administered norfloxacin compared with topically administered gentamicin for the treatment of external ocular bacterial infections. Am J Ophthalmol. 1992;113:638-644.

39.  Bloom PA, Leeming JP, Power W, et al. Topical ciprofloxacin in the treatment of blepharitis and blepharoconjunctivitis. Eur J Ophthalmol. 1994;4:6-12.

40.  Dursun K, Kim MC, Solomon A, et al. Treatment of recalcitrant recurrent corneal erosions with inhibitors of matrix metalloproteinase-9, doxycycline, and corticosteroids. Am J Ophthalmol. 2001;132:8-13.

41.  Gao YY, Di Pascuale MA, Elizondo A, et al. Clinical treatment of ocular demodecosis by lid scrub with tea tree oil. Cornea. 2007;26:136-143.

42.  Dougherty JM, McCulley JP, Silvany RE, et al. The role of tetracycline in chronic blepharitis. Inhibition of lipase production in staphylococci. Invest Ophthalmol Vis Sci. 1991;32:2970-2975.

43.  Cullen SI, Crounse RG. Cutaneous pharmacology of the tetracyclines. J Invest Derm. 1965;45:263-268.

44.  Zengin N, Tol H, Gunduz K, et al. Meibomian gland dysfunction and tear film abnormalities in rosacea. Cornea. 1995;14:144-146.

45.  Gruber GC, Callen JP. Systemic complications of commonly used dermatologic drugs. Cutis. 1978;21:825-829.

46.  Ta CN, Shine WE, McCulley JP, et al. Effects of minocycline on the ocular flora of patients with acne rosacea or seborrheic blepharitis. Cornea. 2003;22:545-548.

47.  Shine WE, McCulley JP, Pandya AG. Minocycline effect on meibomian gland lipids in meibomianitis patients. Exp Eye Res. 2003 Apr;76(4):417-20.

使用此内容应接受我们的免责声明